The liquid biopsy market is rapidly redefining how cancer is detected, monitored, and treated. Unlike traditional tissue biopsies, liquid biopsy relies on a simple blood sample to identify tumor-derived components such as circulating tumor DNA (ctDNA), RNA, and exosomes. This non-invasive approach is emerging as a cornerstone of precision medicine, enabling clinicians to make...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt